Medicare Enrolled

Dr. Mamatha Chivukula, MD

Optician · San Francisco, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
1825 4TH ST, San Francisco, CA 94143
4153531613
In practice since 2006 (20 years)
NPI: 1750353280 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chivukula from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chivukula? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chivukula

Dr. Mamatha Chivukula is an optician specialist in San Francisco, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Chivukula performed 2,179 Medicare services across 984 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chivukula received a total of $58,513 from 9 pharmaceutical and/or device companies across 72 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chivukula is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 35% volume in CA $58,513 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,179
Medicare services
Top 35% in CA for optician
984
Unique beneficiaries
$39
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~109 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tissue pathology examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This intermediate complexity procedure involves specialized techniques to identify abnormalities in the tissue.
592 $32 $142
Tissue staining for diagnosis, additional
An extra laboratory procedure to apply special stains to tissue slides for detailed examination.
434 $25 $108
Moderately high complexity pathology tissue examination
A laboratory test where a pathologist examines tissue samples under a microscope to analyze cellular details. This specific level of complexity involves a moderate to high degree of technical skill and interpretation.
405 $73 $283
Manual microscopic genetic analysis of tumor
A laboratory test that uses a microscope to manually examine tumor tissue for genetic changes.
354 $37 $164
Tissue staining for diagnosis, initial
A laboratory test where special stains are applied to tissue slides to help examine the cells and identify specific characteristics.
273 $31 $142
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician 30 $28 $72
Pathology tissue examination, moderate complexity
A laboratory test where a pathologist examines tissue samples under a microscope to identify abnormalities. This specific level indicates a moderate degree of complexity in the analysis.
26 $10 $60
High complexity pathology tissue examination
A laboratory test where a pathologist examines tissue samples under a microscope using advanced techniques to analyze cellular details.
22 $125 $474
Limited pathology tissue examination
A microscopic examination of tissue samples to identify abnormalities. This limited exam focuses on specific aspects of the tissue rather than a comprehensive analysis.
17 $4 $20
Special stain test for organisms
A laboratory test using special stains on tissue slides to identify microorganisms. The process includes the technical preparation of the slides and a professional interpretation of the results.
14 $24 $102
Computer-assisted genetic tissue analysis
A microscopic genetic analysis of tissue using computer-assisted technology for the initial multiplex procedure.
12 $38 $180
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$58,513
Total received (2018-2024)
Avg $9,752/year across 6 years
Top 4% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
9
Companies
72
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$52,272 (89.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$5,458 (9.3%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$783 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$16,494
2023
$419
2022
$5,599
2021
$4,036
2019
$11,621
2018
$20,343

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$16,350
Roche Diagnostics Corporation
$102
AstraZeneca Pharmaceuticals LP
$42
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Merck Sharp & Dohme Corporation
$22,891
Merck Sharp & Dohme LLC
$16,372
Astellas Pharma US Inc
$5,516
NOVARTIS PHARMACEUTICALS CORPORATION
$5,458
Genentech USA, Inc.
$4,276
Roche Diagnostics Corporation
$3,104
AstraZeneca Pharmaceuticals LP
$720
Foundation Medicine, Inc.
$135
Stemline Therapeutics Inc.
$41
Top 3 companies account for 76.5% of all-time payments
Associated products mentioned in payments ›
Alecensa · CINtec PLUS Cytology · ELZONRIS · FOUNDATIONONE · Herceptin · KEYTRUDA · LYNPARZA · MEKINIST · TD BenchMark IHC/ISH and Special Stains Reagents · TECENTRIQ · iScan Coreo
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (89%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 4% for optician in CA.

Looking for an optician specialist in San Francisco?
Compare opticians in the San Francisco area by procedure volume, costs, and industry payment transparency.
Browse opticians nearby

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chivukula is a mixed practice specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 4% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chivukula experienced with tissue pathology examination, moderate complexity?
Based on Medicare claims data, Dr. Chivukula performed 592 tissue pathology examination, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chivukula receive payments from pharmaceutical companies?
Yes. Dr. Chivukula received a total of $58,513 from 9 companies across 72 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chivukula's costs compare to other opticians in San Francisco?
Dr. Chivukula's average Medicare payment per service is $39. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chivukula) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →